Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001104659-25-052422·Atara Biotherapeutics, Inc.
Schedule 13D ownership disclosure
Atara Biotherapeutics Inc
Common Stock, par value $0.0001 per share · CUSIP: 046513206
Event date: 2025-05-16
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Redmile Group, LLCReported CIK 0001425738
Shares: 705,207.00 · Class: 9.9%
- Jeremy C. GreenReported CIK 0001650527
Shares: 705,207.00 · Class: 9.9%
- RedCo I, L.P.Reported CIK 0001813157
Shares: 347,442.00 · Class: 5.0%
- Redmile Biopharma Investments II, L.P.Reported CIK 0001772230
Shares: 406,137.00 · Class: 5.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-052422
- Form type
- SCHEDULE 13D
- Filer
- Atara Biotherapeutics, Inc.
- CIK
- CIK 1604464
- Filed
- May 23, 2025
- Reporting period
- May 16, 2025
- Description
- Schedule 13D beneficial ownership